Browse Medical Research Based on Condition
FOR ACNE
FOR ADD / ADHD
FOR ADDICTION
FOR ALS
FOR ALZHEIMERS
FOR ANOREXIA
FOR ANXIETY
FOR ATHEROSCLEROSIS
FOR ATHEROSCLEROSIS | The role of the endocannabinoid system in atherosclerosis | |
FOR ATHEROSCLEROSIS | Cannabinoid receptors in atherosclerosis | |
FOR ATHEROSCLEROSIS | The potential use of cannabidiol in the therapy of metabolic syndrome | |
FOR ATHEROSCLEROSIS | Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice |
FOR ARTHRITIS
FOR ASTHMA
FOR AUTISM
FOR BIPOLAR AFFECTIVE DISORDER
FOR BIPOLAR AFFECTIVE DISORDER | Cannabinoids in bipolar affective disorder: A review and discussion of their therapeutic potential | |
FOR BIPOLAR AFFECTIVE DISORDER | Cannabidiol was ineffective for manic episode of bipolar affective disorder | |
FOR BIPOLAR AFFECTIVE DISORDER | Effects of Co-occurring Cannabis Use Disorders on the Course of Bipolar Disorder After a First Hospitalization for Mania | |
FOR BIPOLAR AFFECTIVE DISORDER | Does Cannabis Use Affect Treatment Outcome in Bipolar Disorder?: A Longitudinal Analysis | |
FOR BIPOLAR AFFECTIVE DISORDER | The Use of Cannabis as a Mood Stabilizer in Bipolar Disorder: Anecdotal Evidence and the Need for Clinical Research |
FOR CANCER - GENERAL
FOR CANCER – GENERAL | Cannabidiol as potential anticancer drug | |
FOR CANCER – GENERAL | Cannabidiol inhibits angiogenesis by multiple mechanisms | |
FOR CANCER – GENERAL | The inhibitory effects of cannabidiol on systemic malignant tumors | |
FOR CANCER – GENERAL | Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1 | |
FOR CANCER – GENERAL | Marijuana fights cancer and helps manage side effects |
FOR CANCER - LUNG
FOR CANCER - PROSTATE/COLON
FOR CANCER – PROSTATE/COLON | Towards the use of non-psychoactive cannabinoids for prostate cancer | |
FOR CANCER – PROSTATE/COLON | In Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines | |
FOR CANCER – PROSTATE/COLON | Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent | |
FOR CANCER – PROSTATE/COLON | Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer | |
FOR CANCER – PROSTATE/COLON | Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol |
FOR CANCER - BREAST
FOR CANCER - BRAIN
FOR CANCER - LEUKEMIA
FOR CANCER – LEUKEMIA | Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression | |
FOR CANCER – LEUKEMIA | Cannabidiol-Induced Apoptosis in Human Leukemia Cells | |
FOR CANCER – LEUKEMIA | Cannabidiol Reduces Leukemic Cell Size – But Is It Important? | |
FOR CANCER – LEUKEMIA | Targeting cannabinoid receptors to treat leukemia |
FOR CANCER - SKIN
FOR CANCER - ENDOCRINE
FOR CANCER – ENDOCRINE | Endocannabinoids in endocrine and related tumours | |
FOR CANCER – ENDOCRINE | A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells | |
FOR CANCER – ENDOCRINE | Cannabinoids in pancreatic cancer: Correlation with survival and pain | |
FOR CANCER – ENDOCRINE | Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma |
FOR CANCER - BLADDER
FOR CANCER - PAIN RELIEF
FOR CROHNS & COLITIS
FOR DEPRESSION
FOR ENDOCRINE DISORDERS
FOR FIBROMYALGIA
FOR GLAUCOMA
FOR HEART DISEASE
FOR HUNTINGTONS DISEASE
FOR INFLAMMATION
FOR IRRITABLE BOWEL SYNDROME
FOR KIDNEY DISEASE
FOR LIVER DISEASE
FOR METABOLIC SYNDROME
FOR METABOLIC SYNDROME | The impact of marijuana use on glucose, insulin, and insulin resistance among US adults | |
FOR METABOLIC SYNDROME | The potential use of cannabidiol in the therapy of metabolic syndrome | |
FOR METABOLIC SYNDROME | Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes | |
FOR METABOLIC SYNDROME | Metabolic syndrome in people with a psychotic illness: is cannabis protective? | |
FOR METABOLIC SYNDROME | Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome |
FOR MIGRAINES
FOR MOOD DISORDERS
FOR MOTION SICKNESS
FOR MOTION SICKNESS | Motion sickness, stress and the endocannabinoid system | |
FOR MOTION SICKNESS | Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system | |
FOR MOTION SICKNESS | The Effects of Cannabidiol and Tetrahydrocannabinol on Motion‐Induced Emesis |